Concepedia
Statistics
Publications
31
Citations
4K
H-Index
25
Active since
1967
Affiliations
GlaxoSmithKline (United Kingdom)(Current)
Imperial College London
University College London
GW Pharmaceuticals (United Kingdom)
University of Maryland, Baltimore
Adam Taylor is an author at GlaxoSmithKline (United Kingdom) specializing in life sciences, neuroscience, and medicine.
Publications per year
1967–2022
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
Elizabeth A. Thiele, Eric D. Marsh, Jacqueline A. French et al. · The Lancet · 2018 · 887 citations
Medicine, Neurology, Pharmacology +9
Cannabidiol (CBD) as an Adjunctive Therapy in Schizophrenia: A Multicenter Randomized Controlled Trial
Philip McGuire, Philip Robson, D. Vasile et al. · American Journal of Psychiatry · 2017 · 616 citations · Full text
Medicine, Pharmacotherapy, Psychiatry +17
Encoding of Time-Discounted Rewards in Orbitofrontal Cortex Is Independent of Value Representation
Matthew R. Roesch, Adam Taylor, Geoffrey Schoenbaum · Neuron · 2006 · 311 citations · Full text
Life Sciences, Neuroscience, Psychology +14
The Orbitofrontal Cortex and Ventral Tegmental Area Are Necessary for Learning from Unexpected Outcomes
Yuji K. Takahashi, Matthew R. Roesch, Thomas A. Stalnaker et al. · Neuron · 2009 · 289 citations · Full text
Life Sciences, Neurobiology, Neuroscience +12
The mTORC1/4E-BP1 axis represents a critical signaling node during fibrogenesis
Hannah V. Woodcock, Jessica Eley, Delphine Guillotin et al. · Nature Communications · 2018 · 226 citations · Full text
Life Sciences, Molecular Biology, Pathobiology +17
1–5 of 31